coronary artery bypass grafting; drug eluting stents; left main stem; multivessel disease; SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery trial
SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
Serruys PW, Morice MC, Kappetein AP, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972.
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: Three-year follow-up of the SYNTAX trial
Epub ahead of print. Three-year outcome of most important trial ever of PCI and CABG shows survival benefit of CABG for three-vessel CAD but only for patients with most severe LMS disease
Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: three-year follow-up of the SYNTAX trial. Eur Heart J [Epub ahead of print]. Three-year outcome of most important trial ever of PCI and CABG shows survival benefit of CABG for three-vessel CAD but only for patients with most severe LMS disease.
Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know
DOI 10.1016/j.athoracsur.2006.06.035, PII S000349750601246X
Taggart DP, Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 2006;82:1966-1975. (Pubitemid 44781367)
Randomized trial of stents versus bypass surgery for left main coronary artery disease
Trial of CABG and stents in left main disease with similar findings to SYNTAX but no excess mortality or stroke with CABG in lower-risk patients
Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011;364:1718-1727. Trial of CABG and stents in left main disease with similar findings to SYNTAX but no excess mortality or stroke with CABG in lower-risk patients.
Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the arterial revascularisation trial (ART)
ART Investigators, Confirms excellent outcomes of contemporary CABG in largest randomized trial ever undertaken in cardiac surgery
Taggart DP, Altman DG, Gray AM, et al. ART Investigators. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J 2010;31:2470-2481. Confirms excellent outcomes of contemporary CABG in largest randomized trial ever undertaken in cardiac surgery.
Task Force on Myocardial Revascularization of the European Society of Cardiology ESC and the European Association for Cardio-Thoracic Surgery EACTS; European Association for Percutaneous Cardiovascular Interventions EAPCI, Outstanding summary for current evidence basis for revascularization by stents or surgery and emphasizes importance of multidisciplinary heart team
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010;38(Suppl):S1-S52. Outstanding summary for current evidence basis for revascularization by stents or surgery and emphasizes importance of multidisciplinary heart team.
